Search

everythinglearnresearchcommunity

for

Search:↓

The model better predicts how water-loving and fat-loving substances move through the skin by including tiny pores and hair follicle paths.

The new hair loss treatment combining nitric oxide and minoxidil in a special carrier is effective for hair regrowth.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Rice husk and bran extracts from the Bue Bang 3 CMU variety can potentially treat hair loss due to their antioxidant, anti-inflammatory, and anti-androgenic properties.

SHBG may be a useful early indicator and treatment target for PCOS.

AMH levels in adolescents with PCOS are not affected by their weight.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

Hair cortisol is a reliable stress indicator in cattle but may not be valid for pigs.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

BB4CMU rice bran oil may help treat hair loss and gray hair.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Blumea eriantha DC extract shows strong potential for promoting hair growth.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.